Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo
Open Access
- 26 February 2002
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 86 (5) , 796-802
- https://doi.org/10.1038/sj.bjc.6600137
Abstract
Multiple myeloma is a B cell malignancy. Recently, it has been demonstrated that bone marrow samples of patients with multiple myeloma display an enhanced angiogenesis. The mechanisms involved seem to be multiple and complex. We here demonstrate that the murine 5T multiple myeloma models are able to induce angiogenesis in vitro by using a rat aortic ring assay and in vivo by determining the microvessel density. The rat aortic rings cultured in 5T multiple myeloma conditioned medium exhibit a higher number of longer and more branched microvessels than the rings cultured in control medium. In bone marrow samples from 5T multiple myeloma diseased mice, a statistically significant increase of the microvessel density was observed when compared to bone marrow samples from age-matched controls. The angiogenic phenotype of both 5T multiple myeloma cells could be related, at least in part, to their capacity to produce vascular endothelial growth factor. These data clearly demonstrate that the 5T multiple myeloma models are good models to study angiogenesis in multiple myeloma and will allow to unravel the mechanisms of neovascularisation, as well as to test new putative inhibitors of angiogenesis.Keywords
This publication has 47 references indexed in Scilit:
- Angiogenesis and angiogenic mediators in haematological malignanciesBritish Journal of Haematology, 2000
- The thin red line: Angiogenesis in normal and malignant hematopoiesisExperimental Hematology, 2000
- The 5TMM series: a useful in vivo mouse model of human multiple myelomaThe Hematology Journal, 2000
- Current Status Of Antiangiogenic FactorsBritish Journal of Haematology, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- The Mouse Gene for Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989